Oral steroids in asthma: a double-edged sword
- PMID: 31780458
- DOI: 10.1183/13993003.02034-2019
Oral steroids in asthma: a double-edged sword
Conflict of interest statement
Conflict of interest: M. Gaga reports grants and personal fees from AZ, grants from BI, Elpen, Novartis and Menarini, personal fees from BMS, MSD, Chiesi and Pharmaten, outside the submitted work. Conflict of interest: E. Zervas reports personal fees consultancy and lectures from Astra, Bristol-Myers Squibb, Chiesi, GSK, Elpen, Merck, MSD, Novartis, Menarini and Pfizer, non-financial support for travel, accommodation and meeting expenses from Astra, Bristol-Myers Squibb, Galenica, Chiesi, Elpen, Novartis, Menarini and Roche, outside the submitted work.
Comment on
-
Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study.Eur Respir J. 2019 Nov 28;54(5):1900804. doi: 10.1183/13993003.00804-2019. Print 2019 Nov. Eur Respir J. 2019. PMID: 31515404
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical